TY - JOUR
T1 - Essential roles for NF-κB and a Toll/IL-1 receptor domain-specific signal(s) in the induction of IκB-ζ
AU - Eto, Akiko
AU - Muta, Tatsushi
AU - Yamazaki, Soh
AU - Takeshige, Koichiro
N1 - Funding Information:
We are grateful to Y. Sunakawa for expert technical assistance and T. Irie for the construction of the expression plasmids for IκB-α/β and TRAF6. This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (to T.M., S.Y., and K.T.), and grants from the Sumitomo Foundation (to T.M.), the Naito Foundation (to T.M.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to T.M.), and the Kaibara Foundation (to T.M.).
PY - 2003/2/7
Y1 - 2003/2/7
N2 - IκB-ζ, a new negative-regulator of nuclear factor-κB (NF-κB), is strongly induced by lipopolysaccharide or interleukin-1β stimulation, but not by tumor necrosis factor-α. Here, we analyzed the mechanisms for transcriptional induction of IκB-ζ. IκB-ζ mRNA was induced by overexpression of MyD88 or TRAF6, but not TRAF2. Stimulation of macrophages with peptidoglycan or CpG DNA, which activated Toll-like receptor 2 or 9, respectively, also resulted in IκB-ζ induction. Thus, activation of the MyD88-dependent signaling pathway, commonly found downstream of different Toll/interleukin-1 receptor (TIR) domains, is sufficient for IκB-ζ induction. The induction was inhibited by treatment with various inhibitors of NF-κB activation or by overexpressing IκB-α or β, indicating essential roles for NF-κB in IκB-ζ induction. However, overexpression of the NF-κB subunits induced IκB-α, but not IκB-ζ. These results indicate the existence of another signal essential for IκB-ζ induction, which is specifically mediated by the TIR domain-mediated signaling pathway.
AB - IκB-ζ, a new negative-regulator of nuclear factor-κB (NF-κB), is strongly induced by lipopolysaccharide or interleukin-1β stimulation, but not by tumor necrosis factor-α. Here, we analyzed the mechanisms for transcriptional induction of IκB-ζ. IκB-ζ mRNA was induced by overexpression of MyD88 or TRAF6, but not TRAF2. Stimulation of macrophages with peptidoglycan or CpG DNA, which activated Toll-like receptor 2 or 9, respectively, also resulted in IκB-ζ induction. Thus, activation of the MyD88-dependent signaling pathway, commonly found downstream of different Toll/interleukin-1 receptor (TIR) domains, is sufficient for IκB-ζ induction. The induction was inhibited by treatment with various inhibitors of NF-κB activation or by overexpressing IκB-α or β, indicating essential roles for NF-κB in IκB-ζ induction. However, overexpression of the NF-κB subunits induced IκB-α, but not IκB-ζ. These results indicate the existence of another signal essential for IκB-ζ induction, which is specifically mediated by the TIR domain-mediated signaling pathway.
KW - Innate immunity
KW - IκB-ζ
KW - Macrophage
KW - Nuclear factor-κB
KW - Toll-like receptor
KW - Toll/interleukin-1 receptor domain
KW - Transcriptional induction
UR - http://www.scopus.com/inward/record.url?scp=0037423696&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037423696&partnerID=8YFLogxK
U2 - 10.1016/S0006-291X(02)03082-6
DO - 10.1016/S0006-291X(02)03082-6
M3 - Article
C2 - 12565889
AN - SCOPUS:0037423696
SN - 0006-291X
VL - 301
SP - 495
EP - 501
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 2
ER -